Pangenomic Health Inc. NARA
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.05M | -2.86M | -2.47M | -2.45M | -1.31M |
| Total Depreciation and Amortization | 400.00 | 400.00 | 400.00 | 400.00 | 1.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.64M | 1.28M | 883.90K | 611.80K | 183.10K |
| Change in Net Operating Assets | -181.10K | 55.00K | 224.00K | 606.20K | 974.70K |
| Cash from Operations | -1.60M | -1.53M | -1.36M | -1.23M | -155.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 495.00K | 405.70K | 180.00K | 187.50K | 187.50K |
| Total Debt Repaid | 51.40K | -11.10K | -11.10K | -187.50K | -62.50K |
| Issuance of Common Stock | 1.67M | 1.76M | 1.76M | 1.75M | 88.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00 | -5.90K | -5.90K | 1.70K | -4.30K |
| Cash from Financing | 1.60M | 1.55M | 1.39M | 1.27M | 150.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.10K | 28.20K | 27.50K | 38.60K | -5.10K |